Clinical Trials Directory

Trials / Unknown

UnknownNCT03041610

Pedometer-Based Walking Intervention in Patients With Chronic Heart Failure With Reduced Ejection Fraction

Effect of Pedometer-Based Walking Intervention on Functional Capacity and Neurohumoral Modulation in Patients With Chronic Heart Failure With Reduced Ejection Fraction: a Multicenter Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
202 (actual)
Sponsor
Charles University, Czech Republic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A multicenter randomized controlled trial, with follow-up at 6 and 12 months. Physically inactive participants with chronic heart failure with reduced ejection fraction will be randomly assigned to intervention or control arms. The six-month intervention will consist of an individualized pedometer-based walking program with weekly step goals, monthly face-to-face sessions with the physician, and monthly telephone calls with the research nurse. The intervention will be based on effective behavioral principles (goal setting, self-monitoring, personalized feedback). The primary outcome is the change in 6-minute walk distance at 6 months. Secondary outcomes include changes in serum biomarkers levels, pulmonary congestion assessed by ultrasound, average daily step count measured by accelerometry, anthropometric measures, symptoms of depression, health-related quality of life, self-efficacy, and MAGGIC Risk Score.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWalking interventionThe intervention will be delivered over a six-month period and will consist of: (1) an individualized pedometer-based walking program with weekly step goals, (2) regular visits to the clinic including face-to-face session with the physician, and (3) regular telephone calls with the research nurse in between the face-to-face contacts.

Timeline

Start date
2018-08-01
Primary completion
2023-06-30
Completion
2023-12-30
First posted
2017-02-03
Last updated
2023-10-04

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT03041610. Inclusion in this directory is not an endorsement.